Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence

Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence

Polyfluoro- and perfluoro–alkyl substances (PFAS) are organic chemicals extensively used worldwide for industry and consumer products. Due to their chemical stability, PFAS represent a major cause of environmental pollution. PFAS accumulate in animal and human blood and tissues exerting their toxici...

Full description

Bibliographic Details
Main Authors:	Alessandra Meneguzzi, Cristiano Fava, Marco Castelli, Pietro Minuz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Endocrinology
Subjects:	perfluoroalkyl substances cardiovascular disease obesity diabetes mellitus arterial hypertension platelets
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.706352/full

Similar Items

Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study
by: Guoqi Yu, et al.
Published: (2021-11-01)

Perfluoroalkyl substances exposure and thyroid hormones in humans: epidemiological observations and implications
by: Jung Eun Lee, et al.
Published: (2017-03-01)

Perfluoroalkyl Substance Exposure and the BDNF Pathway in the Placental Trophoblast
by: Melissa J. Marchese, et al.
Published: (2021-07-01)

Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination
by: Clara Amalie Gade Timmermann, et al.
Published: (2017-01-01)

Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review
by: Rachel Margolis, et al.
Published: (2021-09-01)

Exposure to Perfluoroalkyl Substances During Pregnancy and Fetal BDNF Level: A Prospective Cohort Study
by: Guoqi Yu, et al.
Published: (2021-06-01)

Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study
by: Gang Liu, et al.
Published: (2020-01-01)

Pre- and post-diagnostic blood profiles of perfluoroalkyl acids in type 2 diabetes mellitus cases and controls
by: Dolley Charles, et al.
Published: (2020-12-01)

Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011–2012
by: Ryan C. Lewis, et al.
Published: (2015-05-01)

Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults
by: Gisella Pitter, et al.
Published: (2020-09-01)

Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children’s Health
by: Meng-Shan Tsai, et al.
Published: (2018-05-01)

The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy
by: Teresa Dalla Zuanna, et al.
Published: (2021-02-01)

Preliminary study about the detection of perfluoroalkyl substances in eel samples of Lake Garda by liquid chromatography tandem mass high resolution mass spectrometry (LC-HRMS).
by: Maria Nobile, et al.
Published: (2017-05-01)

Aromatic and heterocyclic perfluoroalkyl sulfides. Methods of preparation
by: Vladimir N. Boiko
Published: (2010-08-01)

Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort
by: Anna Birukov, et al.
Published: (2021-06-01)

Perfluoroalkyl substances exposure in early pregnancy and preterm birth in singleton pregnancies: a prospective cohort study
by: Xiaona Huo, et al.
Published: (2020-06-01)

Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study
by: Qian Chen, et al.
Published: (2018-01-01)

Exposure to legacy and novel perfluoroalkyl substance disturbs the metabolic homeostasis in pregnant women and fetuses: A metabolome-wide association study
by: Yuqian Li, et al.
Published: (2021-11-01)

Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
by: Yanfeng Ren, et al.
Published: (2020-08-01)

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
by: Conway BN, et al.
Published: (2018-11-01)

Modeling the global fate and transport of perfluoroalkylated substances (PFAS)
by: Armitage, James M.
Published: (2009)

Power density modulated ultrasonic degradation of perfluoroalkyl substances with and without sparging Argon
by: Takshak Shende, et al.
Published: (2021-08-01)

Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort
by: Iben Have Beck, et al.
Published: (2019-11-01)

Dysregulated lipid and fatty acid metabolism link perfluoroalkyl substances exposure and impaired glucose metabolism in young adults
by: Zhanghua Chen, et al.
Published: (2020-12-01)

Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain
by: Jillian Ashley-Martin, et al.
Published: (2016-01-01)

Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes – A nested case-control study
by: Tessa Schillemans, et al.
Published: (2021-01-01)

Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function
by: Christel Nielsen, et al.
Published: (2020-07-01)

Approche toxicocinétique de la bioaccumulation des composés perfluoroalkyles chez la truite arc-en-ciel (Oncorhynchus mykiss)
by: Vidal, Alice
Published: (2019)

Polybrominated diphenyl ether (PBDE) and poly- and perfluoroalkyl substance (PFAS) exposures during pregnancy and maternal depression
by: Ann M. Vuong, et al.
Published: (2020-06-01)

Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age
by: Jinbo Niu, et al.
Published: (2019-06-01)

Presence of Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) in Food Contact Materials (FCM) and Its Migration to Food
by: Arabela Ramírez Carnero, et al.
Published: (2021-06-01)

Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years – a longitudinal study
by: P. Monica Lind, et al.
Published: (2018-07-01)

Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population
by: S. Salihovic, et al.
Published: (2020-12-01)

Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region
by: Cristina Canova, et al.
Published: (2020-12-01)

Pharmacokinetic bias analysis of an association between clinical thyroid disease and two perfluoroalkyl substances
by: Michael W. Dzierlenga, et al.
Published: (2020-08-01)

Associations between exposure to perfluoroalkyl substances and body fat evaluated by DXA and MRI in 109 adolescent boys
by: Mathilde Lolk Thomsen, et al.
Published: (2021-06-01)

Prenatal Exposure to Perfluoroalkyl Substances and Birth Outcomes; An Updated Analysis from the Danish National Birth Cohort
by: Qi Meng, et al.
Published: (2018-08-01)

Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children
by: Ilona Quaak, et al.
Published: (2016-05-01)

Contamination Profiles of Perfluoroalkyl Substances (PFAS) in Groundwater in the Alluvial–Pluvial Plain of Hutuo River, China
by: Yan Liu, et al.
Published: (2019-11-01)

Method development of total oxidizable precursor assay for perfluoroalkyl acid precursors in domestic sludge
by: Söderlund, Lydia
Published: (2018)